麻豆传媒

Psychiatry >

Pain Management

News, opinions and meeting coverage in psychiatry.

Opiate Alternatives in Cancer Pain

ASRA president discusses the options in this 麻豆传媒 video

Opioid Rx Linked to Higher Mortality in Dialysis Patients

Risks for hospitalization, dialysis discontinuation also higher

AHA: Study Finds Celebrex Safe for Heart

But naproxen not as heart safe as believed

Pregabalin Could Ease Pain, Some Symptoms in IBS-D

Pilot study shows positive results in some pain scores

AAFP Says CMS Should Negotiate Drug Prices

AAFP Congress wraps up with a series of actions targeting cost and access

Survey Finds Many People Lack NSAID Knowledge

Patients fail to ID these drugs or associated risks

Patients Needing High-Dose Opioids May Have Genetic Defects

Defective activity levels require extra meds for pain control

Ob/Gyns Must Be Part of Opioid Epidemic Battle

Screening and treatment crucial for mom and baby

Hep C Virus Outbreak Tied to Unsafe Injection Practices

Calif. prolotherapy clinic shuttered after patients developed HCV infections

Human Birth Defects Seen With Pregabalin

Time for a pregnancy category change?

Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

Opioid Crisis: Scrap Pain as 5th Vital Sign?

Groups call on JC and CMS to re-evaluate policies that could lead to opioid overprescribing

10 Questions: Ilona J. Frieden, MD

'The structure of the system itself is the biggest barrier'

Here's Why You Can't Compare Healthcare to the Airline Industry

There are big differences between the two, says Suneel Dhand, MD

Mu-Opioid Antagonist Effective for Drug-Induced Constipation

But questions remain about whether the need is currently unmet

Zyprexa: Also a Pain Med?

Meta-analysis suggests analgesic effect for antipsychotic drug

Efforts Expand on Abuse-Deterrent Hydrocodone

Hard to abuse -- but what will happen in real world is still unclear

Medical Schools Boost Pain Management Education

In light of opioid epidemic, more schools focus on thoughtful prescribing

Dedicating a Career to Diversity and Disparities

NMA president Edith Mitchell, MD, laments racial gaps in medicine

Will Delay Weaken CDC Opioid Guidance?

Recommendations to limit supply and dosing under fire

Healthcare System Makes Physicians Hypocrites by Enabling Addiction

Why are doctors avoiding treatment of alcoholics?

Experts Weigh In: Where Do People Want to Die?

The answer is not always obvious

'Failure to Communicate' Drives Misdiagnosis

Electronic medical records also need to be improved, says Mark Graber, MD

Doctors Urged to Practice 'Conservative Diagnosis'

And sharing cell phone numbers is a good idea

Patient Registries See Promise and Challenges Ahead

Physician-driven registries adapt to a changing health system

Purdue Pulls New OxyContin Application, and Questions Follow

FDA disavows previous requirement for study of abuse-deterrent formulation

Abandoned Painkiller Makes a Comeback

Here's how the FDA let a widely abused opioid back on the market.

Injecting Opioid Tied to Blood Clotting Disorder

Are most clinicians aware of this side effect of oxymorphone drug abuse?

Allopurinol Doesn't Worsen Acute Gout Attacks

Worries that it might prove unfounded in randomized trial.

What Makes an Opioid Stronger or Weaker Than Morphine?

CDC classification of stronger, weaker, and morphine-equivalent opioids is confusing.

Are RA Patients More Sensitive to Pain?

For many RA is complicated by fibromyalgia.

'Generic' Colchicine to Hit Market

May provide some price relief for gout patients.

Separating Spondyloarthritis From Back Pain Still Problematic

Spinal MRI criteria don't help differentiate SpA from nonspecific pain.

FDA Panel Wants Safer Epidural Steroid Shots

Majority votes to end epidural injections with "particulate" steroids.

FDA Advisers Tackle Epidural Steroid Shots

Focus on adverse neurologic effects.

Gout May Protect Against Alzheimer's Disease

Study showed AD incidence higher over 5 years for patients without gout.

Excerpt From 'Being Mortal ... '

Ivan Ilyich isn't as foreign to today's medicine as we imagine.

Portenoy Opioid Talk Sparks Controversy

Opioid advocate Russell Portenoy's invitation to an upcoming NIH workshop is under fire.

Are Your Patients Using Fake Names?

A case study in the American Journal of Medicine poses a vexing question many healthcare professionals have faced: What should you do when your patients use fraudulent names?

Now What? DEA Tosses Tramadol in Schedule IV

The Drug Enforcement Administration (DEA) scheduled tramadol as a Schedule IV substance -- whats the big fuss about tramadol that led to this decision by the DEA?

鈥�

7